Metis TechBio issues 30.18 million new H-shares after full exercise of over-allotment option

Bulletin Express

Jun 10

Metis TechBio Co., Ltd. announced a post-listing capital increase following the full exercise of the over-allotment option on 10 June 2026. The company allotted 30.18 million new ordinary H-shares at HKD 10.50 per share, expanding its issued share base by 2.87 % from 1.05 billion to 1.08 billion shares.

The transaction, disclosed through a Next Day Disclosure Return to the Hong Kong Stock Exchange, implies gross proceeds of approximately HKD 316.93 million (about 0.32 billion). No treasury-share movements, share repurchases or cancellations were reported.

Following completion, Metis TechBio’s total issued share capital stands at 1.08 billion shares, with no treasury shares outstanding. The company confirmed that the issuance was fully authorised by its board and complied with all relevant listing rules and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1159404210"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1159404210\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1159404210?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 18:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159404210","market":"us","top_or_hot":-1,"title":"Metis TechBio issues 30.18 million new H-shares after full exercise of over-allotment option","media":"Bulletin Express","content":"<p>Metis TechBio Co., Ltd. announced a post-listing capital increase following the full exercise of the over-allotment option on 10 June 2026. The company allotted 30.18 million new ordinary H-shares at HKD 10.50 per share, expanding its issued share base by 2.87 % from 1.05 billion to 1.08 billion shares.</p>\n<p>The transaction, disclosed through a Next Day Disclosure Return to the Hong Kong Stock Exchange, implies gross proceeds of approximately HKD 316.93 million (about 0.32 billion). No treasury-share movements, share repurchases or cancellations were reported.</p>\n<p>Following completion, Metis TechBio’s total issued share capital stands at 1.08 billion shares, with no treasury shares outstanding. The company confirmed that the issuance was fully authorised by its board and complied with all relevant listing rules and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Metis TechBio issues 30.18 million new H-shares after full exercise of over-allotment option</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMetis TechBio issues 30.18 million new H-shares after full exercise of over-allotment option\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-10 18:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Metis TechBio Co., Ltd. announced a post-listing capital increase following the full exercise of the over-allotment option on 10 June 2026. The company allotted 30.18 million new ordinary H-shares at HKD 10.50 per share, expanding its issued share base by 2.87 % from 1.05 billion to 1.08 billion shares.</p>\n<p>The transaction, disclosed through a Next Day Disclosure Return to the Hong Kong Stock Exchange, implies gross proceeds of approximately HKD 316.93 million (about 0.32 billion). No treasury-share movements, share repurchases or cancellations were reported.</p>\n<p>Following completion, Metis TechBio’s total issued share capital stands at 1.08 billion shares, with no treasury shares outstanding. The company confirmed that the issuance was fully authorised by its board and complied with all relevant listing rules and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"07666","symbol_name":"剂泰科技-P","start_time":0,"source_url":"","article_id":"1159404210","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159404210","pubTimestamp":1781086992,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Metis TechBio Co., Ltd. announced a post-listing capital increase following the full exercise of the over-allotment option on 10 June 2026. The company allotted 30.18 million new ordinary H-shares at...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"07666":"剂泰科技-P"},"translate_title":"Metis TechBio超额配股权获全数行使后发行3018万股新H股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"07666":1},"content_text":"Metis TechBio Co., Ltd. announced a post-listing capital increase following the full exercise of the over-allotment option on 10 June 2026. The company allotted 30.18 million new ordinary H-shares at HKD 10.50 per share, expanding its issued share base by 2.87 % from 1.05 billion to 1.08 billion shares.\nThe transaction, disclosed through a Next Day Disclosure Return to the Hong Kong Stock Exchange, implies gross proceeds of approximately HKD 316.93 million (about 0.32 billion). No treasury-share movements, share repurchases or cancellations were reported.\nFollowing completion, Metis TechBio’s total issued share capital stands at 1.08 billion shares, with no treasury shares outstanding. The company confirmed that the issuance was fully authorised by its board and complied with all relevant listing rules and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}